Skip to main content

Advertisement

Log in

Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case–control association study in the Italian population

Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Alopecia Areata (AA) is an autoimmune disease characterized by well-circumscribed patches of hair loss especially from the scalp. Cytotoxic T-lymphocyte antigen 4 (CTLA4) gene, a negative regulator of T cells, has been associated with predisposition to most autoimmune disorders. We evaluated two CTLA4 functional single-nucleotide polymorphisms (SNPs) for potential association with Alopecia Areata in an Italian population using a case–control approach. We genotyped +49AG (rs231775) and CT60 (rs3087243) variants in 130 AA patients and 189 ethnically matched controls by the polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) method. CTLA4 +49AG analysis revealed no statistically significant difference in both the allele and genotype frequencies between patients and controls. As regarding CT60 SNP, we found that AA cases less frequently than healthy subjects carried A/A genotype with a higher prevalence of A/G and G/G genotypes (83.8 and 75.1 %; p = 0.041, OR = 0.58, 95 % CI 0.32–1.03), consistent with a dominant effect of G disease risk allele. In particular, it seemed to exert effects mainly in DQ7-negative patients with a less aggressive form of the disease. Haplotype analysis suggested that the G(+49AG), A(CT60) allelic combination was significantly related to a reduced disease risk (p = 0.014, OR = 0.28, 95 % 0.09–0.82). Altogether, our findings confirm that only CTLA4 CT60 polymorphism seems to be an important genetic determinant of Alopecia Areata development in Italian subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bouqbis L, Izaabel H, Akhayat O, Pérez-Lezaun A, Calafell F, Bertranpetit J, Comas D (2003) Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population. Genes Immun 4:132–137

    Article  PubMed  CAS  Google Scholar 

  2. Brozzetti A, Marzotti S, Tortoioli C, Bini V, Giordano R, Dotta F, Betterle C, De Bellis A, Arnaldi G, Toscano V, Arvat E, Bellastella A, Mantero F, Falorni A, Italian Addison Network (2010) Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies. Eur J Endocrinol 162:361–369

    Article  PubMed  CAS  Google Scholar 

  3. Chen PL, Fann CS, Chang CC, Wu IL, Chiu WY, Lin CY, Yang WS, Chang TC (2008) Family-based association study of cytotoxic T-lymphocyte antigen-4 with susceptibility to Graves’ disease in Han population of Taiwan. Genes Immun 9:87–92

    Article  PubMed  CAS  Google Scholar 

  4. Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, Hwang CY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN (2011) Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol 65:949–956

    Article  PubMed  Google Scholar 

  5. Downie-Doyle S, Bayat N, Rischmueller M, Lester S (2006) Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren’s syndrome. Arthritis Rheum 54:2434–2440

    Article  PubMed  CAS  Google Scholar 

  6. Engelhardt JJ, Sullivan TJ, Allison JP (2006) CTLA-4 overexpression inhibits T cell responses through a CD28–B7-dependent mechanism. J Immunol 177:1052–1061

    PubMed  CAS  Google Scholar 

  7. Gilhar A, Kalish RS (2006) Alopecia areata: a tissue specific autoimmune disease of hair follicle. Autoimmun Rev 5:64–69

    Article  PubMed  Google Scholar 

  8. Gilhar A, Paus R, Kalish RS (2007) Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 117:2019–2027

    Article  PubMed  CAS  Google Scholar 

  9. Gonzalez-Escribano MF, Rodriguez R, Valenzuela A, Garcia A, Garcia-Lozano JR, Nuñez-Roldan A (1999) CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens 53:296–300

    Article  PubMed  CAS  Google Scholar 

  10. Gough SC, Walker LS, Sansom DM (2005) CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204:102–115

    Article  PubMed  CAS  Google Scholar 

  11. Greve B, Simonenko R, Illes Z, Peterfalvi A, Hamdi N, Mycko MP, Selmaj KW, Rozsa C, Rajczy K, Bauer P, Berger K, Weissert R (2008) Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland. Mult Scler 14:153–158

    Article  PubMed  CAS  Google Scholar 

  12. John KK, Brockschmidt FF, Redler S, Herold C, Hanneken S, Eigelshoven S, Giehl KA, De Weert J, Lutz G, Kruse R, Wolff H, Blaumeiser B, Böhm M, Becker T, Nöthen MM, Betz RC (2011) Genetic Variants in CTLA4 Are Strongly Associated with Alopecia Areata. J Invest Dermatol 131:1169–1172

    Article  PubMed  CAS  Google Scholar 

  13. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L, Shi Y (2009) A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 19:519–523

  14. Magistrelli G, Jeannin P, Herbault N, Benoit De Coignac A, Gauchat JF, Bonnefoy JY, Delneste Y (1999) A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 29:3596–3602

    Article  PubMed  CAS  Google Scholar 

  15. Megiorni F, Pizzuti A, Mora B, Rizzuti A, Garelli V, Maxia C, Carlesimo M, Fotruna MC, Delle Chiaie R, Cavaggioni G, Rossi A (2011) Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with alopecia areata in the Italian population. Br J Dermatol 165:823–827

    Article  PubMed  CAS  Google Scholar 

  16. Mora B, Bonamico M, Indovina P, Megiorni F, Ferri M, Carbone MC, Cipolletta E, Mazzilli MC (2003) CTLA-4 +49 A/G dimorphism in Italian patients with celiac disease. Hum Immunol 64:297–301

    Article  PubMed  CAS  Google Scholar 

  17. Oaks MK, Hallett KM, Penwell RT, Stauber EC, Warren SJ, Tector AJ (2000) A native soluble form of CTLA-4. Cell Immunol 201:144–153

    Article  PubMed  CAS  Google Scholar 

  18. Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J, Stenn K (1999) Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 40:242–246

    Article  PubMed  CAS  Google Scholar 

  19. Peakall R, Smouse PE (2006) GENALEX 6: genetic analysis in Excel. Population genetic software for teaching and research. Mol Ecol Notes 6:288–295

    Article  Google Scholar 

  20. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, Kim H, Singh P, Lee A, Chen WV, Meyer KC, Paus R, Jahoda CA, Amos CI, Gregersen PK, Christiano AM (2010) Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466:113–117

    Article  PubMed  CAS  Google Scholar 

  21. Sansom DM, Walker LS (2006) The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev 212:131–148

    Article  PubMed  CAS  Google Scholar 

  22. Scalapino KJ, Daikh DI (2008) CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev 223:143–155

    Article  PubMed  CAS  Google Scholar 

  23. Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:97–98

    Article  PubMed  CAS  Google Scholar 

  24. Steck AK, Rewers MJ (2011) Genetics of type 1 diabetes. Clin Chem 57:176–185

    Article  PubMed  CAS  Google Scholar 

  25. Tazi-Ahnini R, Cox A, McDonagh AJ, Nicklin MJ, di Giovine FS, Timms JM, Messenger AG, Dimitropoulou P, Duff GW, Cork MJ (2000) Genetic analysis of IL1RN and IL1L1 in alopecia areata: strong association with severe disease and early age at onset. Eur J Immunogenet 29:25–30

    Article  Google Scholar 

  26. Tazi-Ahnini R, McDonagh AJ, Cox A, Messenger AG, Britton JE, Ward SJ, Båvik CO, Duff GW, Cork MJ (2001) Association analysis of IL1A and IL1B variants in alopecia areata. Heredity 87:215–219

    Article  PubMed  CAS  Google Scholar 

  27. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506–511

    Article  PubMed  CAS  Google Scholar 

  28. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, McCarthy MI, Kendall-Taylor P, Pearce SH (1999) The cytotoxic T lymphocyte antigen-4 is a major Graves’ disease locus. Hum Mol Genet 8:1195

    Article  PubMed  CAS  Google Scholar 

  29. Viganó P, Lattuada D, Somigliana E, Abbiati A, Candiani M, Di Blasio AM (2005) Variants of the CTLA4 gene that segregate with autoimmune diseases are not associated with endometriosis. Mol Hum Reprod 11:745–749

    Article  PubMed  Google Scholar 

  30. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank all the participants to this study.

Conflict of interest

Non-financial competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesca Megiorni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Megiorni, F., Mora, B., Maxia, C. et al. Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case–control association study in the Italian population. Arch Dermatol Res 305, 665–670 (2013). https://doi.org/10.1007/s00403-013-1348-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-013-1348-3

Keywords

Navigation